Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-046061
Filing Date
2025-05-20
Accepted
2025-05-20 17:28:31
Documents
51
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0242665-10q_drugs.htm   iXBRL 10-Q 392808
2 CERTIFICATION ea024266501ex31-1_drugs.htm EX-31.1 10509
3 CERTIFICATION ea024266501ex31-2_drugs.htm EX-31.2 10510
4 CERTIFICATION ea024266501ex32-1_drugs.htm EX-32.1 4357
5 CERTIFICATION ea024266501ex32-2_drugs.htm EX-32.2 4386
  Complete submission text file 0001213900-25-046061.txt   3533026

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE dmaau-20250331.xsd EX-101.SCH 44443
7 XBRL CALCULATION FILE dmaau-20250331_cal.xml EX-101.CAL 17053
8 XBRL DEFINITION FILE dmaau-20250331_def.xml EX-101.DEF 191100
9 XBRL LABEL FILE dmaau-20250331_lab.xml EX-101.LAB 336344
10 XBRL PRESENTATION FILE dmaau-20250331_pre.xml EX-101.PRE 196780
53 EXTRACTED XBRL INSTANCE DOCUMENT ea0242665-10q_drugs_htm.xml XML 288996
Mailing Address 2 PELICAN DR. FORT LAUDERDALE FL 33301
Business Address 2 PELICAN DR. FORT LAUDERDALE FL 33301 954-870-3104
Drugs Made In America Acquisition Corp. (Filer) CIK: 0002028614 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42467 | Film No.: 25970137
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)